Stifel Financial Corp Reduces Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Stifel Financial Corp lessened its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 12.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 93,074 shares of the company's stock after selling 13,495 shares during the period. Stifel Financial Corp's holdings in Ryan Specialty were worth $6,179,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Xponance Inc. lifted its holdings in shares of Ryan Specialty by 67.2% in the second quarter. Xponance Inc. now owns 20,686 shares of the company's stock valued at $1,198,000 after purchasing an additional 8,312 shares in the last quarter. Geneva Partners LLC bought a new position in shares of Ryan Specialty in the 3rd quarter valued at about $2,537,000. Jennison Associates LLC raised its holdings in shares of Ryan Specialty by 60.2% in the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company's stock valued at $68,054,000 after purchasing an additional 385,366 shares during the period. Susquehanna Fundamental Investments LLC lifted its position in shares of Ryan Specialty by 2,354.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 100,614 shares of the company's stock valued at $5,827,000 after buying an additional 96,514 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new stake in Ryan Specialty in the 3rd quarter valued at $475,000. 84.82% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on RYAN. BMO Capital Markets upgraded Ryan Specialty from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Morgan Stanley began coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective on the stock. Bank of America lifted their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. Barclays lifted their target price on Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research report on Thursday, November 21st. Finally, The Goldman Sachs Group raised their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a research note on Wednesday, October 9th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty currently has a consensus rating of "Hold" and an average target price of $73.50.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the business's stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now directly owns 12,386 shares in the company, valued at $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director David P. Bolger sold 7,055 shares of the company's stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.

Ryan Specialty Trading Up 0.1 %

Shares of Ryan Specialty stock traded up $0.06 on Friday, reaching $67.60. 752,931 shares of the company's stock were exchanged, compared to its average volume of 868,149. The firm's 50-day moving average is $70.87 and its two-hundred day moving average is $64.42. The company has a market capitalization of $17.70 billion, a P/E ratio of 87.82, a price-to-earnings-growth ratio of 1.54 and a beta of 0.67. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $75.97.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting analysts' consensus estimates of $0.41. The firm had revenue of $604.69 million during the quarter, compared to analysts' expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company's revenue for the quarter was up 20.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 earnings per share. Sell-side analysts predict that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty's payout ratio is currently 57.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.